179 related articles for article (PubMed ID: 29396013)
1. Coexistence of anti-Jo1 and anti-signal recognition particle antibodies in a polymyositis patient.
Melguizo Madrid E; Fernández Riejos P; Toyos Sáenz de Miera FJ; Fernández Pérez B; González Rodríguez C
Reumatol Clin (Engl Ed); 2019; 15(6):e111-e113. PubMed ID: 29396013
[TBL] [Abstract][Full Text] [Related]
2. An unusual association: anti-Jo1 and anti-SRP antibodies in the serum of a patient with polymyositis.
Vincze M; Molnár PA; Tumpek J; Szollosi L; Gyetvai A; Kapitány A; Dankó K
Clin Rheumatol; 2010 Jul; 29(7):811-4. PubMed ID: 20221841
[TBL] [Abstract][Full Text] [Related]
3. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
[TBL] [Abstract][Full Text] [Related]
4. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
Sibilia J; Chatelus E; Meyer A; Gottenberg JE; Sordet C; Goetz J
Presse Med; 2010 Oct; 39(10):1010-25. PubMed ID: 20655695
[TBL] [Abstract][Full Text] [Related]
5. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
[TBL] [Abstract][Full Text] [Related]
6. [Autoantibodies specifically detected in patients with polymyositis/dermatomyositis].
Sato S
Nihon Rinsho Meneki Gakkai Kaishi; 2006 Apr; 29(2):85-93. PubMed ID: 16651706
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in polymyositis and dermatomyositis.
Ghirardello A; Bassi N; Palma L; Borella E; Domeneghetti M; Punzi L; Doria A
Curr Rheumatol Rep; 2013 Jun; 15(6):335. PubMed ID: 23591825
[TBL] [Abstract][Full Text] [Related]
8. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.
Dugar M; Cox S; Limaye V; Blumbergs P; Roberts-Thomson PJ
Intern Med J; 2011 Sep; 41(9):674-9. PubMed ID: 20059602
[TBL] [Abstract][Full Text] [Related]
9. Rituximab therapy in necrotizing autoimmune myopathy associated with anti-SRP antibody: A clinical case review.
Nóvoa Medina FJ; Gutiérrez Martínez J; González González Y; Romero Díaz B; Machín García S; Rosas Romero A
Reumatol Clin (Engl Ed); 2018; 14(6):379-381. PubMed ID: 28389200
[TBL] [Abstract][Full Text] [Related]
10. [Anti-signal recognition particle autoantibody positive myopathy].
Bodoki L; Vincze M; Hortobágyi T; Griger Z; Csonka T; Dankó K
Ideggyogy Sz; 2014 Sep; 67(9-10):347-53. PubMed ID: 25518264
[TBL] [Abstract][Full Text] [Related]
11. Hyperacute muscle weakness in an unusual coexistence of antisignal recognition particle and anti-Mi-2 antibodies.
Akintayo RO; Agbola OF; Adeyemo AW; Adelowo O
BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28720599
[TBL] [Abstract][Full Text] [Related]
12. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
Mescam-Mancini L; Allenbach Y; Hervier B; Devilliers H; Mariampillay K; Dubourg O; Maisonobe T; Gherardi R; Mezin P; Preusse C; Stenzel W; Benveniste O
Brain; 2015 Sep; 138(Pt 9):2485-92. PubMed ID: 26198592
[TBL] [Abstract][Full Text] [Related]
13. Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy.
Hengstman GJ; ter Laak HJ; Vree Egberts WT; Lundberg IE; Moutsopoulos HM; Vencovsky J; Doria A; Mosca M; van Venrooij WJ; van Engelen BG
Ann Rheum Dis; 2006 Dec; 65(12):1635-8. PubMed ID: 16679430
[TBL] [Abstract][Full Text] [Related]
14. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies.
Ladislau L; Arouche-Delaperche L; Allenbach Y; Benveniste O
Curr Rheumatol Rep; 2018 Aug; 20(9):56. PubMed ID: 30074107
[TBL] [Abstract][Full Text] [Related]
15. Clinical features associated with the presence of anti-Ro52 and anti-Ro60 antibodies in Jo-1 antibody-positive anti-synthetase syndrome.
Yamaguchi K; Tang Q; Poland P; Reay DP; Gregory A; Aggarwal R; Oddis CV; Ascherman DP
Front Immunol; 2024; 15():1399451. PubMed ID: 38895121
[TBL] [Abstract][Full Text] [Related]
16. Anti-Jo-1 autoantibodies and the immunopathogenesis of autoimmune myositis.
Tsui FW; Siminovitch KA
Int Rev Immunol; 1991; 7(3):225-35. PubMed ID: 1721933
[TBL] [Abstract][Full Text] [Related]
17. [Anti-Jo-1 autoantibodies (anti-histidyl tRNA synthetase autoantibodies)].
Hirakata M; Mimori T
Nihon Rinsho; 1999 Nov; 57 Suppl():431-4. PubMed ID: 10635875
[No Abstract] [Full Text] [Related]
18. A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.
Satoh M; Tanaka S; Ceribelli A; Calise SJ; Chan EK
Clin Rev Allergy Immunol; 2017 Feb; 52(1):1-19. PubMed ID: 26424665
[TBL] [Abstract][Full Text] [Related]
19. [Anti-SRP myopathy].
Suzuki S
Rinsho Shinkeigaku; 2011 Nov; 51(11):961-3. PubMed ID: 22277439
[TBL] [Abstract][Full Text] [Related]
20. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
Srivastava P; Dwivedi S; Misra R
Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
